arabinofuranosyluracil has been researched along with Carcinoma, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, S; Hirooka, C; Ichijo, M; Kiyozuka, Y; Noda, T; Oku, M; Yamamoto, T | 1 |
| Burchenal, JH; Fanucchi, MP; Fox, JJ; Leyland-Jones, B; Watanabe, KA; Young, CW | 1 |
2 other study(ies) available for arabinofuranosyluracil and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
[Intraperitoneal (i.p.) chemotherapy in the management of ovarian cancer--pharmacokinetics and methods of sequential i.p. chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosyluracil; Carcinoma, Squamous Cell; Child; Cisplatin; Cystadenocarcinoma; Cytarabine; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusion Pumps; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Teratoma | 1990 |
Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU).
Topics: Adult; Aged; Antineoplastic Agents; Arabinofuranosyluracil; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Central Nervous System Diseases; Drug Evaluation; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Platelet Count; Uridine; Vomiting | 1985 |